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Abstract
The deleted in colorectal cancer (DCC) gene encodes the netrin-1 receptor DCC, a transmembrane 
protein required for the guidance of commissural axons. Germline DCC mutations disrupt the 
development of predominantly commissural tracts in the central nervous system (CNS) and cause 
a spectrum of neurological disorders. Monoallelic, missense and predicted loss-of-function DCC 
mutations cause congenital mirror movements, isolated agenesis of the corpus callosum, or both. 
Biallelic, predicted loss-of-function DCC mutations cause developmental split brain syndrome. 
Although the underlying molecular mechanisms leading to disease remain poorly understood, they 
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are thought to stem from reduced or perturbed Netrin-1 signaling. Here we review the 26 reported 
DCC mutations associated with abnormal CNS development in humans, including 14 missense 
and 12 predicted loss-of-function mutations, and discuss their associated clinical characteristics 
and diagnostic features. We provide an update on the observed genotype-phenotype relationships 
of congenital mirror movements, isolated agenesis of the corpus callosum and developmental split 
brain syndrome, and correlate this to our current understanding of the biological function of DCC 
in the development of the CNS. All mutations and their associated phenotypes were deposited into 
a locus specific LOVD (https://databases.lovd.nl/shared/genes/DCC).
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Background
DCC (MIM# 120470) encodes the DCC netrin-1 receptor protein, an evolutionarily 
conserved, single-pass transmembrane glycoprotein belonging to the immunoglobulin 
superfamily of cell adhesion molecules [Fearon, et al., 1990; Keino-Masu, et al., 1996]. 
DCC is located at 18q21.2 and spans chr18:52,340,172-53,535,903 (GRCh38/hg38) 
[Hedrick, et al., 1994]. The canonical DCC transcript consists of 29 exons that encode a 159 
kDa (1447 amino acid) protein. DCC is a putative dependence receptor originally thought to 
function as a tumor suppressor gene, although this role has not been proven in vivo and 
remains controversial [Fearon, et al., 1990; Llambi, et al., 2001; Williams, et al., 2006; Bin, 
et al., 2015]. More recently, the role of DCC in the development of the central nervous 
system (CNS) was established [Keino-Masu, et al., 1996; Fazeli, et al., 1997; Finger, et al., 
2002; Srour, et al., 2010; Jamuar, et al., 2017; Marsh, et al., 2017].
DCC is expressed by commissural axons and binds Netrin-1 (NTN1), a secreted protein 
encoded by the NTN1 gene (MIM# 601614) which functions both locally and diffusely as a 
bifunctional guidance cue [Kennedy, et al., 1994; Keino-Masu, et al., 1996; Blasiak, et al., 
2017]. Both DCC and NTN1 are expressed throughout the developing mouse and human 
brain, with distinct but complementary spatial and temporal expression patterns [Shu, et al., 
2000; Ren, et al., 2006; Harter, et al., 2010; Jamuar, et al., 2017]. DCC is required for the 
transduction of NTN1-induced attractive and long-range repulsive signaling in the 
coordinated outgrowth and guidance of commissural axons that cross the anatomical midline 
of the body [Chan, et al., 1996; Keino-Masu, et al., 1996; Hong, et al., 1999].
The development of commissural tracts is dependent on neurons forming synaptic 
connections with their target cells located on the opposite side of the CNS. To achieve this, 
neurons extend commissural axons tipped with a specialized, motile sensing device called a 
growth cone [Tessier-Lavigne and Goodman, 1996]. Growth cones express an array of axon 
guidance receptors such as DCC. The binding of a chemotactic (diffusible) or haptotactic 
(substrate-bound) guidance cue to an axon guidance receptor generates a permissive or non-
permissive axonal outgrowth signal, or an attractive or repulsive directional response 
[Tessier-Lavigne and Goodman, 1996; Raper and Mason, 2010]. The signals transduced by 
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axon guidance receptors converge to modulate the assembly of growth cone filamentous 
actin and cytoskeletal microtubules required for directing axon outgrowth and guidance 
towards or away from a guiding cell population [Luo, 2002; Kahn and Baas, 2016].
Monoallelic and biallelic germline DCC mutations disrupt commissural axon guidance 
[Srour, et al., 2010; Jamuar, et al., 2017; Marsh, et al., 2017; Welniarz, et al., 2017b]. These 
disruptions impair the normal development and function of tracts such as the corticospinal 
tract (CST) and corpus callosum (CC). Monoallelic DCC mutations cause congenital mirror 
movements (MMs, MIM# 157600) in association with abnormal midline crossing of the 
CST, isolated agenesis of the CC (iACC, MIM# 217990), or both [Srour, et al., 2010; Marsh, 
et al., 2017]. Alternatively, biallelic DCC mutations leading to predicted loss-of-function 
(LoF) cause developmental split brain syndrome (DSBS, MIM# 617542), a more complex 
syndrome associated with agenesis of the corpus callosum (ACC) as well as widespread 
failure of commissural tracts throughout the rest of the CNS, with or without MMs [Jamuar, 
et al., 2017].
Variant Database
We created a new repository for all reported disease-associated DCC sequence variants using 
the Leiden Open Variation Database (LOVD 3.0: http://databases.lovd.nl/shared/genes/
DCC) [Fokkema, et al., 2011]. The International Research Consortium for the Corpus 
Callosum and Cerebral Connectivity (IRC5, http://www.irc5.org) encourages users to 
register and submit data, including clinical and neuroimaging phenotypic data.
Variant Nomenclature
The nomenclature for DNA and protein sequence variants adheres to the guidelines of the 
Human Genome Variation Society (HGVS) [den Dunnen and Antonarakis, 2000]. Variant 
descriptions were based on the following Genbank reference sequences: NG_013341.2, 
NM_005215.3 and NP_005206.2. We utilized the Mutalyzer program (https://mutalyzer.nl/) 
to validate variant descriptions. At the time of publication, the DCC Locus Reference 
Genomic sequence (LRG_1107) was under curation and pending approval [MacArthur, et 
al., 2014].
Variants
To date, 26 unique DCC mutations have been associated with MMs, iACC and DSBS in 66 
individuals from 25 unrelated families (Figure 1]. There are 29 reported unaffected 
heterozygous mutation carriers; 11 confirmed carriers from 7 unrelated families assessed for 
MMs and brain abnormalities using magnetic resonance imaging (MRI) or computed 
tomography (CT), and 18 carriers from 9 unrelated families that appear clinically unaffected 
but have not been assessed for MMs and brain abnormalities. There are no reported 
unaffected individuals with biallelic, predicted LoF DCC mutations.
Monoallelic or biallelic missense (14 out of 24; 58%) and monoallelic, predicted LoF (10 
out of 24; 42%) DCC mutations may cause MMs, iACC, or both (Table 1]. These include 
one case each where two heterozygous missense mutations were inherited in cis p.
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(Met1217Val;p.Ala1250Thr) or in trans p.(Gly470Asp);(p.(Gly803Arg) and a biallelic p.
(Gln691Lys) mutation observed in conjunction with an interhemispheric cyst and modest 
learning difficulties [Méneret, et al., 2014a; Jamuar, et al., 2017; Marsh, et al., 2017]. 
Alternatively, biallelic, predicted LoF (2 out of 2; 100%) DCC mutations cause DSBS. 
Germline transmission of the mutant allele, except for a p.(Gly803Arg) mutation that arose 
de novo, was confirmed in all pedigrees where parental genotypes were available [Méneret, 
et al., 2014a]. DCC-MMs and DCC-iACC are both associated with reduced penetrance: 
MMs ≈42% penetrance and iACC ≈26% penetrance [Marsh, et al., 2017]. In contrast, DSBS 
appears to be fully penetrant. Monoallelic DCC mutations are also associated with variable 
expressivity and affected individuals within one family may present with MMs, iACC, or 
both [Marsh, et al., 2017]. All DCC residues altered by a missense mutation are conserved 
throughout vertebrate evolution, although it should be noted that Dcc has been lost in 
passeriformes and galliformes during bird evolution, and are either novel (8 out of 14; 57%) 
or found at a minor allele frequency of less than 0.5% (6 out of 14; 43%) in the Exome 
Aggregation Consortium (ExAC) (Supp. Table S1) [Friocourt, et al., 2017]. Predicted LoF 
DCC mutations include nine frameshift mutations, two truncating mutations and an 
intragenic deletion encompassing exons 4 and 5 (Table 1].
Structure and Function
DCC is composed of four structurally distinct, evolutionarily conserved regions: four 
extracellular immunoglobulin-like (Ig-like) domains, six extracellular fibronectin type III-
like (FN3) domains, a transmembrane domain, and an intracellular domain with three 
conserved P motifs (Supp. Figure S1) [Kolodziej, et al., 1996]. Each region of DCC appears 
to have a unique functional role required for the transduction of NTN1 signaling.
The distal N-terminal region of DCC contains four Ig-like domains and three inter-domain 
linkers that together comprise 371 amino acids (residues 46–417). These domains fold into a 
horseshoe-like configuration that appears necessary for DCC to transduce NTN1-signaling 
[Chen, et al., 2013]. The proximal N-terminal region of DCC contains six FN3 domains and 
five inter-domain linkers that together comprise 612 amino acids (residues 429–1041). 
Regions within the 4th, 5th and 6th FN3 domains bind NTN1 [Bennett, et al., 1997; 
Geisbrecht, et al., 2003; Finci, et al., 2014; Xu, et al., 2014]. This extracellular binding 
brings two DCC proteins into close proximity, enabling their intracellular domains to 
homodimerize and initiate the recruitment of multi-protein complexes required to transduce 
NTN1 signaling [Stein, et al., 2001; Mille, et al., 2009].
The DCC ligand, NTN1, is an extracellular protein belonging to the laminin superfamily and 
is composed of three structurally distinct regions: a laminin-like domain (LN), three 
laminin-type epidermal growth factor-like domains (LE) and a netrin-like domain (NTR) 
[Serafini, et al., 1994]. NTN1 has three distinct DCC-binding sites (binding site 1, 2 and 0; 
BS1, BS2 and BS0) (Figure 2]. BS1 is located on the third LE of NTN1 and interacts 
exclusively with the 5th FN3 domain of DCC. This site functions as a DCC-specific binding 
site and is stabilized by several hydrophobic interactions supported by a surrounding 
network of hydrogen bonds (Figure 3A) [Finci, et al., 2014]. BS2 is located on the first and 
second LE domains of NTN1 and interacts with a distinct region of the 5th FN3 domain as 
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well as the N-terminal region of the 6th FN3 domain of DCC. This site functions as a generic 
binding site that can interact with receptors other than DCC [Finci, et al., 2014]. BS2 is 
predominantly stabilized by a group of sulfate and chloride anions that neutralize positively 
charged patches on NTN1 and DCC residues located at the binding interface (Figure 3B) 
[Finci, et al., 2014]. The adaptable nature of BS2 allows binding to the 1st and 2nd Ig-like 
domains of members of the unc-5 netrin receptor (UNC5, MIM# 603610) family of 
repulsive axon guidance proteins, which appear to have a higher affinity for BS2 relative to 
DCC [Leonardo, et al., 1997; Hong, et al., 1999; Geisbrecht, et al., 2003; Finci, et al., 2014]. 
As a result, UNC5 are able to outcompete DCC at BS2 and switch an attractive growth cone 
response (mediated via NTN1-induced DCC homodimerization) to a repulsive response 
(mediated via NTN1-induced DCC and UNC5 heterodimerization) [Hong, et al., 1999; 
Finci, et al., 2014; Grandin, et al., 2016]. In contrast to BS1 and BS2, BS0 is located on the 
LN of NTN1 and interacts with the 4th FN3 domain of DCC [Xu, et al., 2014]. This NTN1 
protein is different to the one simultaneously engaged at BS1 and BS2, but binds the same 
DCC protein occupied at BS1 (Figure 3C]. The binding of DCC by a second NTN1 protein 
at BS0 is thought to generate a signaling cluster important for the transduction of a 
directional response towards or away from a guiding cell population [Finci, et al., 2015].
Taken together, these studies indicate that NTN1 forms two distinct binding clusters through 
BS0, BS1, and BS2 and that these clusters underpin its bifunctionality as an attractive and 
repulsive guidance cue. The first cluster involves the 4th and 5th FN3 domains of one DCC 
protein at BS0 and BS1, while the second cluster involves the 5th and 6th FN3 domains of a 
second DCC protein or the 1st and 2nd Ig-like domains of an UNC5 family member protein 
at BS2. However, it should be noted that the actual in vivo binding structure may differ as 
these studies utilized a recombinant NTN1 protein lacking its NTR domain and different 
truncated DCC fragments, both lacking the NTN1 binding region in its entirety [Finci, et al., 
2014; Xu, et al., 2014].
The importance of the 4th, 5th and 6th FN3 domains are highlighted by the significant 
enrichment of DCC missense mutations linked to MMs and/or iACC within these NTN1 
binding regions compared with missense variants located in these domains in the ExAC 
(Figure 4 A–B) [Marsh, et al., 2017]. This enrichment is most significant for monoallelic, 
missense mutations linked to iACC (5 out of 9; 56%) and suggests that missense mutations 
may cause disease through different, perhaps more complex mechanisms compared to those 
mutations leading to predicted LoF and haploinsufficiency. This may be due to reduced or 
perturbed NTN1-induced axon repulsion and/or attraction caused by dysfunction of the 
mutant DCC protein in both a mutant-mutant homodimer and wild-type-mutant homodimer 
complex. Additional studies are required to determine whether these missense alterations 
cause complete or partial LoF or perhaps gain-of-function as antimorphic, hypermorphic or 
neomorphic mutations. For instance, it remains to be determined whether mutant DCC 
proteins are stably expressed and trafficked to the plasma membrane or aberrantly 
sequestered in the cytoplasm like mutant NTN1 proteins [Méneret, et al., 2017]. However, 
absence of the DSBS phenotype in an individual with a biallelic p.(Gln691Lys) missense 
mutation suggests that these mutant proteins may retain some residual function [Jamuar, et 
al., 2017].
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The DCC transmembrane domain comprises 24 amino acids (residues 1098 to 1122). To 
bind NTN1, DCC must correctly partition its transmembrane domain within the cell plasma 
membrane. The palmitoylation and localization of the transmembrane domain to lipid rafts 
(cholesterol- and sphingolipid-enriched membrane subdomains of the plasma membrane) 
has been demonstrated to be necessary for DCC to transduce NTN1-induced axon guidance 
and outgrowth [Guirland, et al., 2004; Herincs, et al., 2005].
The intracellular, C-terminal region of DCC contains 324 amino acids (residues 1123–1447) 
and is required to transduce NTN1 signals into appropriate growth cone responses. Within 
the C-terminal region there are three conserved P motifs referred to as P1 (encoded by 
residues 1150–1167), P2 (encoded by residues 1330–1365) and P3 (encoded by residues 
1424–1447) [Kolodziej, et al., 1996]. These P motifs are involved in numerous protein-
protein interactions and phosphorylation cascades required for the intracellular transduction 
of NTN1 signaling [Hong, et al., 1999; Stein and Tessier-Lavigne, 2001; Li, et al., 2004; 
Ren, et al., 2004; Fothergill, et al., 2014]. For example, the NTN1-induced, intracellular 
homodimerization of the DCC P3 motifs initiates downstream signaling events that generate 
an attractive growth cone response [Stein, et al., 2001; Li, et al., 2002; Li, et al., 2004; Liu, 
et al., 2004; Meriane, et al., 2004; Ren, et al., 2004; Ren, et al., 2008]. Alternatively, the 
NTN1-induced, intracellular heterodimerization of the DCC P1 motif and the DCC binding 
(DB) motif of UNC5 family members initiates downstream signaling events that generate a 
long-range, repulsive growth cone response [Hong, et al., 1999; Keleman and Dickson, 
2001; Li, et al., 2006; Norris, et al., 2014].
Genotype-Phenotype Correlation
Monoallelic frameshift and nonsense DCC mutations are predicted to result in 
haploinsufficiency via nonsense mediated mRNA decay or rapid turnover of the truncated 
protein, resulting in reduced NTN1 binding [Srour, et al., 2010]. This is in contrast to DCC 
missense mutations that likely generate a full-length protein within the cell [Meriane, et al., 
2004; Finci, et al., 2014]. DCC proteins carrying a missense mutation may be non-
functional, hypomorphic or may have an altered function that imparts a dominant effect 
through perturbed NTN1 binding, receptor multimerization and/or downstream signaling 
[Meriane, et al., 2004; Finci, et al., 2014]. Monoallelic, truncating DCC mutations predicted 
to result in haploinsufficiency are frequently associated with MMs (8 out of 10; 80%) or 
MMs with iACC (2 out of 10; 20%). DCC missense mutations are less frequently associated 
with MMs (5 out of 14; 36%). Instead, the majority of these mutations are associated with 
iACC (7 out of 14; 50%) or MMs with iACC (2 out of 14; 14%). This disparity may be due 
to developmental differences between the CC and the subcerebrally projecting neurons that 
comprise the CST. The neuronal populations that comprise each of these tracts are 
molecularly distinct and uniquely employ DCC and NTN1 signaling to reach their 
contralateral targets [Molyneaux, et al., 2007; Fothergill, et al., 2014]. Therefore, a missense 
or predicated LoF DCC mutation may differentially affect commissural versus subcerebral 
axon trajectories, thus leading to iACC, MMs or both [Marsh, et al., 2017]. Although these 
observations do support the hypothesis that distinct disease mechanisms contribute to DCC-
MMs or DCC-iACC, additional functional investigations are required to confirm this 
correlation. These investigations could utilize in vivo techniques such as in utero 
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electroporation or conditional gene knockout to study the effect loss or dysfunction of Dcc 
has on the outgrowth and guidance of axons extending from specific populations of 
projection neurons during development.
Monoallelic, missense mutations located within the NTN1 binding sites of DCC appear to 
be strongly associated with iACC [Marsh, et al., 2017]. Indeed, the majority of DCC 
mutations located within the 4th and 5th FN3 domains are associated with iACC (5 out of 6; 
83%). Interestingly, the p.(Val793Gly) and p.(Gly805Glu) missense mutations located 
directly within the NTN1 binding interface are associated with a more severe phenotype that 
features both iACC and MMs [Marsh, et al., 2017]. Previous studies have shown a 
differential disruption to NTN1-induced axon attraction and repulsion dependent on the 
location of the mutated DCC residue within the NTN1 binding interface (Figure 4C) [Finci, 
et al., 2014]. Consequently, DCC mutations located within the NTN1 binding interface may 
cause more severe disruptions to commissural axon outgrowth and guidance that result in a 
phenotype that features both iACC and MMs. Overall, it appears that the majority of 
missense iACC mutations localize to the FN3 domains (7 out of 9; 78%), highlighting the 
importance of these domains to DCC function and callosal development.
The observed structure of pedigrees with monoallelic, predicted LoF DCC mutations has 
suggested a sex-bias in MMs and iACC phenotype expression [Sharafaddinzadeh, et al., 
2008; Srour, et al., 2009; Marsh, et al., 2017]. Indeed, within these pedigrees a significant 
proportion of males displayed MMs, whilst iACC was almost exclusively detected in 
females [Marsh, et al., 2017]. Sex differences in callosal morphology have previously been 
linked with testosterone levels during prenatal brain development [Moffat, et al., 1997; 
Chura, et al., 2010]. Consistent with these observations, RNAseq and RT-qPCR analyses 
have detected a significant dose-dependent increase in DCC expression in testosterone-
treated neural stem cells derived from human embryonic stem cells [Marsh, et al., 2017]. 
These findings suggest that iACC may occur when the expression of DCC falls below a 
threshold level during CC development, as would occur more commonly in females. 
However, given the incomplete penetrance observed in both sexes, the phenotype must also 
be influenced by additional genetic, epigenetic and/or environment factors [Marsh, et al., 
2017]. Furthermore, the sex-specific nature of this phenotype imbalance remains to be 
verified as reciprocal analyses utilizing estrogens have not been reported. Additional in vivo 
investigations are required to evaluate the potential impact the hormonal context during 
brain development has on DCC expression and whether it influences the expressivity of the 
MMs and iACC phenotype.
Biological Significance
Commissural axons form connections between the left and right sides of the brain that are 
required for the transfer and integration of information generated by sensory, motor and 
associative neurons. These connections are defined anatomically as either commissures or 
decussations. Whereas commissures cross the midline to form predominantly homotopic 
connections, decussations descend or ascend along the neuraxis before crossing the midline 
to form connections with different neuronal populations. For instance, axons within the CC 
arch over the lateral ventricles in a segregated, orderly manner to form predominantly 
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homotopic connections with their target cells in the contralateral cerebral hemisphere [Zhou, 
et al., 2013]. These connections function by mediating higher-order brain processes and 
facilitating the integration of sensory and motor information between the two cerebral 
hemispheres [Paul, et al., 2007]. Within the CST, axons cross the midline at the medulla to 
form the pyramidal decussation between the brainstem and the spinal cord [Nathan, et al., 
1990]. The connections formed by axons within the crossed CST facilitate the voluntary and 
unilateral movement of the contralateral distal limbs [Welniarz, et al., 2017a]. Several 
additional tracts within the brainstem are disrupted in DSBS [Jamuar, et al., 2017]. These 
appear to include the decussation of the superior cerebellar peduncles (also referred to as the 
commissure of Wernekinck) that connects the cerebellum to the midbrain, and the 
commissural tract linking the lateral abducens and medial occulomotor nerves, required for 
conjugate horizontal eye movement [Jen, 2008; Jamuar, et al., 2017].
The function of each commissural tract is underpinned by the transcriptionally distinct 
neuronal subtypes that comprise it [Molyneaux, et al., 2007; Harada, et al., 2016]. For 
instance, the CC is formed from pioneer axons extending from neurons in the cingulate 
cortex and follower axons extending from callosal projection neurons located within layers 
II/III and Va of the cerebral cortex [Fame, et al., 2011]. In comparison, the CST is comprised 
of an array of axons extending from subcerebrally projecting neurons situated within layer 
Vb of the cortex [Dum and Strick, 1991; Harwell, et al., 2012]. Notably, the tracts associated 
with the brainstem originate from diverse nuclei. For example, the transverse 
pontocerebellar projections arise from pontine nuclei while cranial nerves originate from 
nuclei located throughout the midbrain, pons and medulla. To reach their contralateral 
targets, these neuronal subtypes extend axons that express a unique repertoire of receptors, 
including DCC, on their growth cones [Dickson and Zou, 2010; Evans and Bashaw, 2010]. 
The tightly regulated, spatiotemporal expression of axon guidance receptors and their 
ligands control the development of tracts such as the CC and CST [Chedotal and Richards, 
2010]. As highlighted below, our understanding of the development of these tracts and the 
associated role of DCC and NTN1 signaling in humans has been predominantly informed by 
the study of these biological processes in mice.
The formation of the CC is complex and dependent on the execution of several 
developmental steps. Briefly, these include midline patterning and remodeling of the 
interhemispheric fissure by astroglia to create a permissible substrate for commissural axons 
to cross the midline [Silver, et al., 1982; Hayhurst, et al., 2008; Okada, et al., 2008; Gobius, 
et al., 2016); secretion of guidance cues by populations of glia and neurons situated around 
the midline [Shu and Richards, 2001; Shu, et al., 2003; Unni, et al., 2012); pioneering of the 
callosal tract by axons extending from neurons in the cingulate cortex [Rash and Richards, 
2001); and fasciculation of callosal axons with pioneer axons as they grow towards and 
across the midline [Koester and O’Leary, 1994; Rash and Richards, 2001]. Dcc and Ntn1 are 
required for the normal development of the CC and their loss or dysfunction in mice is 
associated with complete ACC [Serafini, et al., 1996; Fazeli, et al., 1997; Finger, et al., 
2002]. While both pre-crossing pioneer and callosal axons express Dcc, only the former 
axonal population appears to be attracted towards the midline by Ntn1 [Shu, et al., 2000; 
Fothergill, et al., 2014]. Instead, it has been shown that pre-crossing callosal axons utilize 
Dcc and Ntn1 signaling to attenuate the repulsive signaling of Robo1 and Slit2 (another 
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axon guidance receptor-ligand pair) to approach and cross the midline [Stein and Tessier-
Lavigne, 2001; Fothergill, et al., 2014]. The expression of Dcc in post-crossing callosal 
axons is subsequently downregulated, thereby restoring the repulsive effect of Robo1 and 
Slit2 signaling to direct axons away from the midline and towards their targets in the 
contralateral cerebral hemisphere [Shu, et al., 2000; Fothergill, et al., 2014].
The subcerebrally projecting neurons that comprise the CST mainly originate from the 
primary motor and premotor areas of the cortex and follow a stereotyped route to innervate 
their targets in the spinal cord [Dum and Strick, 1991]. During development, axons from 
these projection neurons converge and descend through the internal capsule and cerebral 
peduncles of the midbrain before entering the ventral brainstem where they form the 
medullary pyramids. Most CST projections then cross the midline in the caudal region of the 
medulla to form the pyramidal decussation, before projecting inferiorly in the spinal cord to 
synapse with lower motor neurons or interneurons in the ventral spinal cord to facilitate 
voluntary movement of the limbs [Welniarz, et al., 2017a]. Dcc is required for the normal 
development of the CST in mice and Dcc dysfunction is associated with a failure of the CST 
to cross the midline at the level of the pyramidal decussation [Finger, et al., 2002; Welniarz, 
et al., 2017b]. However, Dcc does not appear to be expressed in the brainstem CST of mice 
as it is significantly downregulated in the distal portion of the axon that grows beyond the 
internal capsule [Shu, et al., 2000; Finger, et al., 2002]. Interestingly, the role of Dcc in the 
development of the CST at the midline was reported to be non-cell autonomous as 
conditional knockout of Dcc in the cortex (and therefore the CST) caused ACC but not a 
failure of the CST to cross the midline [Welniarz, et al., 2017b].
In the brainstem and spinal cord, Dcc is present on commissural axons which are guided 
circumferentially from the dorsal roof plate towards the ventral floor plate (where midline 
crossing occurs) in response to Ntn1 [Holley, 1982; Tessier-Lavigne, et al., 1988; Yee, et al., 
1999; Dominici, et al., 2017; Varadarajan, et al., 2017]. The attractive response of these 
commissural axons to Ntn1 is regulated by Dcc in partnership with Robo3, another axon 
guidance receptor required for normal development of the hindbrain and spinal cord 
[Marillat, et al., 2004; Sabatier, et al., 2004; Chen, et al., 2008; Zelina, et al., 2014]. 
Pioneering studies utilizing embryonic chick spinal cord demonstrated that this axonal 
navigation is reliant on a ventral-dorsal gradient of Ntn1 diffused from the floor plate 
[Kennedy, et al., 1994]. Subsequent studies in mice also detected a similar graded 
distribution of Ntn1 extending from the floor plate, supporting the observation that Ntn1 
functions as a long-range diffusible chemoattractant [Serafini, et al., 1996; Kennedy, et al., 
2006]. However, recent reports have revised this model by demonstrating that Ntn1 
produced by neural progenitors in the ventral ventricular zone of hindbrain and spinal cord 
neuroepithelium are essential for commissural axon extension towards the ventral midline in 
embryonic mice [Dominici, et al., 2017; Varadarajan, et al., 2017; Yamauchi, et al., 2017]. 
These reports propose that, in mice, commissural axons are directed via Dcc-dependent 
haptotaxis towards the ventral midline by Ntn1 produced and deposited at the pial surface of 
the hindbrain and spinal cord, not via a diffusible gradient of Ntn1 emanating from the floor 
plate [Dominici, et al., 2017; Varadarajan and Butler, 2017; Varadarajan, et al., 2017; 
Yamauchi, et al., 2017]. Therefore, regardless of how Ntn1 is presented to axons, it is clear 
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that it functions to direct Dcc-expressing commissural axons towards the ventral midline of 
the hindbrain and spinal cord during development.
Clinical Relevance
MMs are involuntary movements on one side of the body that mirror voluntary movements 
made on the opposite side [Cincotta and Ziemann, 2008]. DCC-MMs commonly present in 
infancy or early childhood and persist stably into adulthood [Srour, et al., 2009; Srour, et al., 
2010; Depienne, et al., 2011; Méneret, et al., 2014a; Franz, et al., 2015; Marsh, et al., 2017]. 
DCC-MMs manifest in the fingers and hands but may also be present in the forearms, toes 
and feet in a subset of affected individuals (Supp. Table S2) [Srour, et al., 2010; Méneret, et 
al., 2014a; Marsh, et al., 2017]. With effort, some affected individuals can partly suppress 
these involuntary movements [Srour, et al., 2009]. Individuals with DCC-MMs exhibit a 
range of functional disabilities besides difficulties in fine bimanual activities. These include 
fatigue, spontaneous muscle contractions and pain in the upper limbs during extended 
manual activities such as writing, as well as general clumsiness and compensatory 
maneuvers to inhibit involuntary movements [Depienne, et al., 2011; Méneret, et al., 2014a; 
Meneret, et al., 2015; Marsh, et al., 2017]. As a result, DCC-MMs may preclude affected 
individuals from professions and social activities that demand sustained or complex 
bimanual coordination. Individuals with DCC-MMs do not appear to exhibit any additional 
clinical manifestations and have a normal developmental outcome [Sharafaddinzadeh, et al., 
2008; Srour, et al., 2009; Srour, et al., 2010; Depienne, et al., 2011; Méneret, et al., 2014a; 
Franz, et al., 2015; Meneret, et al., 2015; Marsh, et al., 2017; Welniarz, et al., 2017b]. 
However, only a subset of individuals diagnosed with DCC-MMs are reported to have 
undergone brain imaging (12 out of 42; 29%) and formal neuropsychological evaluation (2 
out 42; 5%) and therefore the phenotypic spectrum of DCC-MMs remains to be defined 
[Marsh, et al., 2017].
DCC-MMs are observed in association with midline axon guidance defects, evidenced by 
decreased crossing of descending corticospinal motor projections at the pyramidal 
decussation [Marsh, et al., 2017; Welniarz, et al., 2017b]. This reduction of crossed 
projections occurs in conjunction with a relative, reciprocal increase of uncrossed 
projections [Marsh, et al., 2017; Welniarz, et al., 2017b]. Concordantly, unilateral 
transcortical stimulation of the primary hand motor area elicits both normal, contralateral 
and abnormal, ipsilateral motor evoked potentials in individuals with DCC-MMs [Cincotta, 
et al., 1994; Srour, et al., 2010; Welniarz, et al., 2017b]. As a result, DCC-MMs are thought 
to originate from the bilateral transmission of motor commands through normally crossed 
and abnormally uncrossed, fast-conducting CST projections in the spinal cord [Srour, et al., 
2010; Welniarz, et al., 2015; Welniarz, et al., 2017b].
Individuals with monoallelic, missense DCC mutations may also present with iACC, with or 
without MMs [Marsh, et al., 2017]. ACC describes the partial or complete absence of the 
CC and is characterized by the failure of callosal axons to cross the midline. Apart from the 
abnormalities typically expected to be associated with ACC, such as the absence of the 
hippocampal commissure and cingulate gyrus and dysmorphic lateral ventricles or 
colpocephaly, individuals with iACC do not present with additional brain abnormalities 
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[Kuker, et al., 2003; Cesaretti, et al., 2016]. Individuals with DCC-iACC may present with 
complete iACC (14 out of 19; 74%) or partial iACC (5 out of 19; 26%) [Marsh, et al., 2017]. 
Approximately half of these individuals also present with MMs (9 out of 19; 47%), which 
suggests that DCC-iACC may frequently present as part of a global disorder of midline 
crossing [Parrish, et al., 1979; Paul, et al., 2007; Marsh, et al., 2017]. Other callosal 
abnormalities such as hypoplasia (a uniformly thin CC) and/or dysplasia (abnormal CC 
shape) have not been observed in individuals with DCC-iACC [Marsh, et al., 2017]. 
Individuals with DCC-iACC show no consistent additional gross brain abnormalities in the 
posterior commissure, ventricular system, cerebral cortex, white matter, hippocampi, 
brainstem, basal ganglia, cerebral and cerebellar peduncles, cerebellar vermis and 
hemispheres, optic chiasm, and pituitary gland (Figure 5) [Marsh, et al., 2017]. However, the 
anterior commissure of some DCC-iACC individuals may be enlarged [Marsh, et al., 2017]. 
Enlargement of the anterior commissure is also observed in a minority of individuals with 
ACC and has been suggested to represent a compensatory mechanism to maintain 
connectivity between the cerebral hemispheres [Barr and Corballis, 2002; Hetts, et al., 
2006].
The clinical manifestations of DCC-iACC vary, but they are generally associated with a 
favorable development outcome with no intellectual disability [Marsh, et al., 2017) (Supp. 
Table S2). Still, individuals with DCC-iACC do commonly exhibit typical neurobehavioral 
consequences associated with ACC, such as impairments in emotional and social 
functioning in addition to attention, language, visuospatial and literacy and numeracy 
deficits [Paul, et al., 2007; Sotiriadis and Makrydimas, 2012; Marsh, et al., 2017].
Biallelic, DCC mutations leading to predicted LoF are associated with DSBS, a complex 
syndrome associated with a broad disorganization of white-matter tracts throughout the CNS 
[Jamuar, et al., 2017]. The features of DSBS include absence of all commissures (including 
the CC, anterior and posterior), brainstem defects (including hypoplasia of the pons and 
midbrain), horizontal gaze palsy and progressive scoliosis with a variable age of onset 
(Figure 5].
Several features of DSBS overlap with HGPPS1 (MIM# 607313), a congenital syndrome 
caused by biallelic mutations in the axon guidance receptor ROBO3 (MIM# 608630) [Jen, et 
al., 2004; Chan, et al., 2006; Sicotte, et al., 2006]. Robo3 is a functional, intracellular 
binding partner of Dcc, expressed by commissural axons in the brainstem and spinal cord 
[Marillat, et al., 2004; Sabatier, et al., 2004; Zelina, et al., 2014]. The overlapping feature of 
horizontal gaze palsy in DSBS and HGPPS1 affected individuals appears to originate from 
hindbrain midline axon guidance defects in tracts that control conjugate horizontal eye 
movement [Jen, et al., 2004; Chan, et al., 2006; Sicotte, et al., 2006; Renier, et al., 2010; 
Jamuar, et al., 2017]. The pathogenesis of progressive scoliosis in both these disorders is 
unknown, but may stem from defective spinal commissural interneurons or abnormal 
development of extrapyramidal projections [Jen, et al., 2004; Rabe Bernhardt, et al., 2012; 
Jamuar, et al., 2017]. Diffusion MRI of one DSBS individual with a biallelic p.
(Val263Alafs*36) mutation revealed several tract defects, including absence of the 
decussation of the superior cerebellar peduncles and transverse pontocerebellar projections 
[Jamuar, et al., 2017]. These commissural defects are also observed in individuals with 
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HGPPS1 [Sicotte, et al., 2006]. Individuals with DSBS may also present with MMs, which 
are associated with the reduced midline crossing of descending CST projections at the 
pyramidal decussation [Jamuar, et al., 2017]. This is in contrast to individuals with HGPPS1 
who do not display MMs, a feature attributed to an uncrossed CST leading to reversed 
lateralization of motor control [Jen, et al., 2004]. It is currently unknown why some 
individuals with DSBS and complete loss of DCC do not present with MMs. However, like 
HGPPS1, this may be due to a complete, rather than partial, failure of the descending CST to 
cross the midline. The other major clinical manifestations of DSBS include intellectual 
disability, global developmental delay and hypotonia (Supp. Table S2) [Jamuar, et al., 2017]. 
Individuals with DSBS have a poor developmental outcome compared to individuals with 
DCC-iACC, likely attributed to additional brain abnormalities affecting the formation of 
other commissural tracts [Jamuar, et al., 2017; Marsh, et al., 2017].
Diagnostic Strategies
The clinical assessment and diagnosis of MMs is commonly based on the Woods and Teuber 
severity scale developed in 1978 [Woods and Teuber, 1978]. The assessment typically 
consists of three different hand motor tasks. The level of MMs visible in the mirror hand is 
scored on a scale between 1 - barely discernible repetitive movement and 4 - movement 
equal to that expected for the intended hand [Woods and Teuber, 1978]. The majority of 
individuals with DCC-MMs score between 2 (slight but unsustained or stronger, but briefer, 
repetitive movement) and 3 (strong and sustained repetitive movement). Recently, 
accelerometer gloves were utilized to quantitatively evaluate MMs in a multiplex MMs 
family with a monoallelic, p.(Pro551Leufs*26) DCC mutation [Franz, et al., 2015]. These 
gloves detect subtle movement, in contrast to electromyography that measures the electrical 
activity produced by skeletal muscle [Franz, et al., 2015]. Interestingly, the accelerometer 
gloves led to the diagnosis of subclinical MMs in two additional family members initially 
diagnosed as unaffected carriers following standardized neurological assessment. The 
current penetrance of DCC-MMs is approximately 42% [Marsh, et al., 2017]. In light of 
these findings, it appears likely that a proportion of clinically unaffected mutation carriers 
have subclinical MMs and that the true prevalence of DCC-MMs may be higher. It remains 
to be determined whether subclinical DCC-MMs are associated with a similar, or perhaps 
less severe, failure of the CST to cross the midline.
Brain abnormalities such as ACC can be readily identified utilizing ultrasonography, CT and 
MRI. MRI is considered the gold standard for the diagnosis of ACC because of its superior 
sensitivity and ability to differentiate iACC and complex ACC (ACC with additional brain 
abnormalities) [Rapp, et al., 2002; Wright, et al., 2010; Tercanli and Prufer, 2016]. The 
distinction of the latter is important in a prenatal setting as individuals with iACC generally 
have a favorable developmental outcome compared to those with complex ACC [Sotiriadis 
and Makrydimas, 2012; Edwards, et al., 2014; D’Antonio, et al., 2016; des Portes, et al., 
2017]. Likewise, individuals with DCC-iACC have a favorable developmental outcome 
while individuals with DSBS have a poor developmental outcome. The current penetrance of 
DCC-iACC is approximately 26% [Marsh, et al., 2017]. However, brain imaging studies 
have not been completed for the majority of affected individuals originating from DCC-
MMs-only families (29 out of 36; 81%). Given its mild clinical phenotype and concomitance 
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with DCC-MMs, it is probable that further brain imaging studies will identify DCC-iACC in 
a proportion of these mutation-positive individuals. Like DCC-MMs, the true prevalence of 
DCC-iACC is likely to be higher than current estimates.
Genetic screening for monoallelic DCC mutations is recommended for individuals 
presenting with MMs, iACC or both, in the absence of intellectual disability. Alternatively, 
screening for biallelic DCC mutations with predicted LoF is recommended for individuals 
presenting with characteristic features of DSBS, including horizontal gaze palsy, ACC, 
brainstem defects and progressive scoliosis. Direct sequencing of coding exons and flanking 
intronic regions using germline DNA is advised when screening for DCC mutations. Given 
the mild clinical phenotype and high rates of incomplete penetrance associated with DCC-
MMs and DCC-iACC, cascade testing should be considered for all extended family 
members at risk of inheriting a mutant allele. Differential genetic diagnoses for DCC-MMs 
include NTN1 and RAD51 (MIM# 179617) [Depienne, et al., 2012; Méneret, et al., 2014a; 
Méneret, et al., 2017); for DCC-iACC include CDK5RAP2 (MIM# 608201, although only 
one family has been described to date [Jouan, et al., 2016)); and for DSBS include ROBO3 
(note: individuals with HGPPS1 do not suffer from intellectual disability and have normal 
forebrain commissures, consistent with the predominant role of ROBO3 in the developing 
hindbrain and spinal cord) [Jen, et al., 2004; Chan, et al., 2006; Sicotte, et al., 2006]. 
However, the low diagnostic yield of genetic screening studies indicates that additional MMs 
and iACC disease genes remain to be identified and therefore mutations in DCC, NTN1, 
RAD51 and CDK5RAP2 will not always be identified in individuals with these phenotypes 
[Méneret, et al., 2014a; Méneret, et al., 2014b; Franz, et al., 2015; Jamuar, et al., 2017; 
Marsh, et al., 2017; Méneret, et al., 2017].
Variants of Unknown Significance
The classification and clinical interpretation of a DCC sequence variant is challenged by the 
variable expressivity of monoallelic DCC mutations and the incomplete penetrance 
associated with DCC-MMs and DCC-iACC. It may also be complicated by phenotypic 
heterogeneity and the identification of other potential pathogenic variants in an individual. In 
this context and in the absence of sufficient evidence to classify a DCC variant as pathogenic 
or not, it is recommended to report such a genetic alteration as a variant of unknown 
significance (VUS).
To illustrate these issues, we describe individual N-0083-01 with two novel, monoallelic 
VUS predicted to be damaging by most in silico tools: a maternally inherited 
NM_005215.3:c.916G>A:p.(Gly306Arg) DCC alteration and a de novo 
NM_001270399.1:c.1246G>A:p.(Gly416Ser) TUBA1A (MIM# 602529) alteration (Supp. 
Table S3) [Jamuar, et al., 2017]. The individual has complete ACC with a small pons and 
small inferior aspect of the midbrain, but no definite cortical malformation as would be 
expected to result from a pathogenic TUBA1A mutation [Keays, et al., 2007]. However, the 
individual does not exhibit the mild clinical manifestations associated with DCC-iACC. 
Instead, she has global developmental delay and severe cognitive impairments with 
significant emotional and behavioral problems in addition to spastic diplegia, strabismus and 
cortical visual impairment (Supp. Table S4). As exemplified by this case, additional disease 
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modeling and physiologically relevant functional assays are required to better inform the 
classification and clinical interpretation of DCC sequence variants, particularly for those 
causing missense alterations.
Future Prospects
Mutations in DCC disrupt the development of predominantly commissural tracts in the CNS 
and cause a spectrum of neurological disorders ranging from MMs and iACC with a normal 
or favorable developmental outcome, to DSBS with a poor developmental outcome. These 
findings are consistent with previously reported animal models and support the notion that 
DCC, in partnership with NTN1, functions as a master regulator of commissural axon 
guidance at the midline [Fazeli, et al., 1997; Finger, et al., 2002; Varadarajan, et al., 2017; 
Welniarz, et al., 2017b]. Future investigations into the underlying molecular mechanisms 
leading to these disorders will strengthen current genotype-phenotype correlations. However, 
insightful correlations will be dependent on the multidisciplinary phenotyping of affected 
individuals, employing standardized neurological assessment, formal neuropsychological 
evaluation and brain imaging studies. Utilization of advanced neuroimaging modalities, such 
as diffusion MRI-based tractography and functional MRI, will also aid our understanding of 
how the brains of these affected individuals is wired in the context of DCC dysfunction or 
LoF during development. We anticipate the DCC locus specific LOVD will function as a 
central data repository that will assist researchers to establish these important genotype-
phenotype correlations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Linear DCC gene schematic with protein domain structure depicting the location of all 
reported mutations. Square, predicted loss-of-function; circle, missense mutation; red, 
DSBS; green, MMs; blue, iACC; orange, MMs and iACC. The NTN1 binding region is 
indicated. IgC2, immunoglobulin-like type C2 domain; FN3, fibronectin type III –like 
domain; TM, transmembrane domain; P1–3, conserved P motifs. The NP_005206.2 
reference sequence is used. Image modified from Marsh et al. 2017.
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(A) Schematic drawing of DCC with protein domain structure depicting the location of the 
NTN1 binding sites (BS) 0, 1 and 2. (B) Structure of NTN1 protein depicting the location of 
its DCC binding sites BS0, BS1 and BS2. (C) NTN1 residues (colored spheres) that bind the 
4th and 5th FN3 domains of DCC (yellow and green ribbons, respectively) are conserved 
throughout evolution. Conserved residues are colored red, non-conserved residues are 
colored blue. IgC2, immunoglobulin-like type C2 domain; FN3, fibronectin type III –like 
domain; P1–3, conserved P motifs; NTR, netrin-like domain; LE, laminin-type epidermal 
growth factor-like domain; LN, laminin-like domain.
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(A) Binding site 1 (BS1) and BS2 of the NTN1/DCC complex (PDB ID: 4URT). (B) BS2 of 
the NTN1/DCC complex (PDB ID: 4URT). (C) BS0 of the NTN1/DCC complex (PDB ID: 
4PLO). Structure of NTN1 (transparent molecular surface) bound to DCC FN3 domains 
(orange ribbons). The expansion of the red dotted box region shows the NTN1 (magenta 
sticks) and DCC (gray or white sticks) involved in binding at BS1, BS2 or BS0. Hydrogen 
bonds are represented by dotted black lines. FN3, fibronectin type III –like domain; PDB ID, 
Protein Data Bank identification.
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The fibronectin type III –like (FN3) domains are required for NTN1 binding and DCC 
function. (A) Enrichment of DCC missense mutations linked to MMs and/or iACC within 
the NTN1 binding region. Structure of NTN1/DCC complex. DCC is depicted as an orange 
ribbon and NTN1 as a white solvent accessible surface. DCC missense mutations located 
within the FN3–4 and FN3–5 domains are represented as blue spheres (PDB ID: 4PLO). (B) 
Expansion of the binding interface (red dotted box in A) with NTN1 residues colored blue 
and critical DCC residues represented as purple sticks. Mutation of V793 and G805 to Gly 
and Glu, respectively, is associated with both MMs and iACC. (C) Sequence alignment of 
the DCC FN3 domains. Residues highlighted in green are predicted to be directly involved 
in NTN1 binding by Finci et al. 2014 and/or Xu et al. 2014. Residues in yellow are missense 
mutations associated with MMs and/or iACC. Residues in blue are missense mutations 
associated with MMs and/or iACC that are also predicted to be directly involved in NTN1 
binding. The NP_005206.2 reference sequence is used. PDB ID, Protein Data Bank 
identification. Image modified from Marsh et al. 2017.
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Axial MRI of control (A) and individuals with complete DCC-iACC (D), partial DCC-iACC 
(G) and DSBS (J). Midsagittal MRI of control (B) and individuals with complete DCC-
iACC (E), partial DCC-iACC with absence of the rostrum and genu (H) and DSBS (K). 
Coronal MRI of control (C) and individuals with complete DCC-iACC (F), partial DCC-
iACC (I) and DSBS (L). iACC, isolated agenesis of the corpus callosum; DSBS, 
developmental split brain syndrome. Images A-I adapted from Marsh et al. 2017. Images J-L 
adapted from Jamuar et al. 2017.
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